Skip to main content
Pfizer10-Q: Restructuring

Pfizer launches Manufacturing Optimization Program phase targeting $1.5 billion savings with $4.0 billion costs

Source: Autobound Signal API · 104 signals tracked for Pfizer · updated

Get Pfizer's live signals in Claude or ChatGPT, or by API

AskWhat changed at Pfizer this week? Use Autobound signals for pfizer.com.

What happened

Pfizer announced the next phase of its multi-year Manufacturing Optimization Program targeting network structure changes, product portfolio enhancements, and operational efficiencies to achieve $1.5 billion in additional savings through 2029. The company anticipates $4.0 billion in one-time costs to achieve these savings, which may indicate upcoming demand for supply chain restructuring...

Source

SEC EDGARAug 4, 2026

Quarterly report (Form 10-Q)

Pfizer 10-Q for Quarter ended Jun 28, 2026

Filing excerpt

In the third quarter of 2026, we announced the next phase of our multi-year program designed to reduce our cost of goods sold focused on network structure changes, product portfolio enhancements and additional operational efficiencies which is expected to deliver additional anticipated savings of approximately $1.5 billion through 2029, some of which is expected to begin being realized in 2027.

sec.gov/Archives/edgar/data/78003/000007800326000095/pfe-20260628.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Restructuring

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jun 28, 2026
Fiscal year end
06/28
Filed
Aug 4, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$4B (one-time costs to achieve manufacturing optimization savings through 2029)

Details

CIK
78003
Accession number
0000078003-26-000095
Timeframe
Multi year
Quarter
Q2
Filing year
2026
Period end date
Jun 28, 2026
Why it matters
Change management needs
Signal category
Workforce

Extraction

Confidence
High
Relevance
80%
Sentiment
Neutral
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
restructuring

Use this data

Get every 10-Q signal for Pfizer and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Pfizer this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/acc22552-f438-4310-bb2b-dcf8a20d0015 returns this record as JSON. POST /v1/companies/enrich returns every signal for pfizer.com.

{
  "signal_id": "acc22552-f438-4310-bb2b-dcf8a20d0015",
  "signal_type": "sec-10q",
  "signal_subtype": "restructuring",
  "detected_at": "2026-11-09T06:32:59.131+00:00",
  "company": {
    "name": "Pfizer",
    "domain": "pfizer.com"
  },
  "data": {
    "detail": "Pfizer announced the next phase of its multi-year Manufacturing Optimization Program targeting network structure changes, product portfolio enhancements, and operational efficiencies to achieve $1.5 billion in additional savings through 2029. The company anticipates $4.0 billion in one-time costs to achieve these savings, which may indicate upcoming demand for supply chain restructuring, facility transition, and operational consulting services.",
    "metrics": {
      "timeframe": "multi_year",
      "dollar_context": "one-time costs to achieve manufacturing optimization savings through 2029",
      "dollar_millions": 4000
    },
    "quarter": "Q2",
    "summary": "Pfizer launches Manufacturing Optimization Program phase targeting $1.5 billion savings with $4.0 billion costs",
    "excerpts": "In the third quarter of 2026, we announced the next phase of our multi-year program designed to reduce our cost of goods sold focused on network structure changes, product portfolio enhancements and additional operational efficiencies which is expected to deliver additional anticipated savings of approximately $1.5 billion through 2029, some of which is expected to begin being realized in 2027.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/78003/000007800326000095/pfe-20260628.htm",
    "filing_date": "2026-08-04",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/28",
    "period_end_date": "2026-06-28",
    "sales_relevance": "Change management needs",
    "signal_category": "workforce"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.